Thomas O. Daniel
2012
In 2012, Thomas O. Daniel earned a total compensation of $3.6M as President, Research and Early Development at Celgene.
Compensation breakdown
| Non-Equity Incentive Plan | $859,993 |
|---|---|
| Option Awards | $957,823 |
| Salary | $625,000 |
| Stock Awards | $1,018,083 |
| Other | $97,685 |
| Total | $3,558,584 |
Daniel received $1M in stock awards, accounting for 29% of the total pay in 2012.
Daniel also received $860K in non-equity incentive plan, $957.8K in option awards, $625K in salary and $97.7K in other compensation.
Rankings
In 2012, Thomas O. Daniel's compensation ranked 1,902nd out of 11,487 executives tracked by ExecPay. In other words, Daniel earned more than 83.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,902 out of 11,487 | 83rd |
Division Manufacturing | 684 out of 4,253 | 84th |
Major group Chemicals And Allied Products | 155 out of 1,198 | 87th |
Industry group Drugs | 87 out of 920 | 91st |
Industry Pharmaceutical Preparations | 72 out of 700 | 90th |
Source: SEC filing on April 30, 2015.
Daniel's colleagues
We found four more compensation records of executives who worked with Thomas O. Daniel at Celgene in 2012.